Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3969 results

Sort By:

Context Interventions: Social Modeling and Initial Treatment Experience

Study ID: NCT04646460
Start Date: 2025-12-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Observed Success

Observed Failure

Experienced Success

Experienced Failure

Sponsor

Trustees of Dartmouth College

Source: clinicaltrials.gov

Share:
Add to list

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Substudy B: CLL Patients

Study ID: NCT06916767
Start Date: 2025-07
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

BAFF CAR-T

Obinutuzumab

Cyclophosphamide

Fludarabine

Sponsor

Paolo Caimi, MD

Source: clinicaltrials.gov

Share:
Add to list

Quality of Life Before and After Transcatheter Ablation in Children With Arrythmias

Study ID: NCT06808204
Start Date: 2025-08-01
End Date: 2027-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Questionnaire

questionnaire

questionnaire

questionnaire

questionnaire

questionnaire

Sponsor

Lyon Civilian Hospices

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)

Study ID: NCT07028801
Start Date: 2025-07-31
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

3000

Intervention / Treatment

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Sponsor

Ningbo Rongan Biological Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients

Study ID: NCT06187701
Start Date: 2026-03
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Co-Active Therapeutic Theatre (Co-ATT)

Sponsor

Boston Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma

Study ID: NCT06880601
Start Date: 2025-11-01
End Date: 2029-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

52

Intervention / Treatment

Teclistamab

Sponsor

Italian group Hematological Diseases of the Adult

Source: clinicaltrials.gov

Share:
Add to list

The Impact of Improved Vagal Function on Periaqueductal Gray Connectivity

Study ID: NCT05618067
Start Date: 2025-07
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

breathing exercise training

Sponsor

Virginia Commonwealth University

Source: clinicaltrials.gov

Share:
Add to list

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies

Study ID: NCT07020260
Start Date: 2025-09-01
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

18

Intervention / Treatment

CAR T-cell and Cellular Therapies

Sponsor

Princess Maxima Center for Pediatric Oncology

Source: clinicaltrials.gov

Share:
Add to list

Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Study ID: NCT06375460
Start Date: 2025-07
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Focused App Prompt

No App Prompt

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Posterior Mitral Isthmus Line With Vein of Marshall Ethanolisation Compared With Anterior Mitral Lines in Patients With Persistent Atrial Fibrillation

Study ID: NCT06962176
Start Date: 2025-07
End Date: 2027-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

146

Intervention / Treatment

Anterior Mitral Line Ablation

Posterior Mitral Isthmus Ablation with Vein of Marshall Ethanol Infusion

Sponsor

Az angry-jan of

Source: clinicaltrials.gov

Share:
Add to list